Vico Therapeutics

Rewriting the Code of Neurological Disease

Leiden · Founded 2019 · $103.0M raised

Headquarters
Leiden
Founded
2019
Business Model
B2B
Website
vicotx.com
Total Funding
$103.0M
Last Round
$12.0M Extension RoundJun 2024
Rounds
3

About

Vico Therapeutics is a neurology genetic medicine company headquartered in Leiden, the Netherlands, pioneering targeted treatments for devastating disorders. Founded in 2019, the company's lead program, VO659, is an antisense oligonucleotide (ASO) therapy designed to target the CAG repeat expansion mutation underlying Huntington's disease and multiple spinocerebellar ataxias, addressing nine distinct polyglutamine diseases through a single molecule while carefully preserving essential protein function.

Summary

Vico Therapeutics is a Biotech company based in Leiden, founded in 2019. It has raised $103.0M in total across 3 rounds, most recently a $12.0M Extension Round round in Jun 2024. Investors include Kurma Partners, Seroba Life Sciences and LSP Life Sciences Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Extension RoundExtension RoundJun 2024
$12.0M

Sign up to see all 3 rounds

Series A through Extension Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vico Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/vico-therapeutics"><img src="https://indexed.vc/api/badge/company/vico-therapeutics" alt="Vico Therapeutics on Indexed.vc" width="260" height="76" /></a>